Skip to main content

Thursday, January 20, 2005

Ingen Technologies Signs Agroworx - Pure Produce� Program Expected to Add $5M in Revenue by Year End 2005

�

For Immediate Release:

Calimesa, CA- January 20, 2005: Ingen Technologies’ (OTC:IGTN) announced today that it has contracted with hydroponic and aeroponic farming pioneer AgroWorx, Inc. to manage the Company’s Pure Produce� development program in Southern California and Asia.

As part of Ingen’s Pure Produce� program, the Company intends to build the first of several hydroponic facilities. Agroworx , a pioneer in the hydroponic and aeroponic farming industry, will develop food based resources for local communities, and plant based resources for the pharmaceutical markets for use to generate drugs difficult or expensive to produce in any other way. The first facility is being financed through Ingen’s Asian investment groups, and scheduled for construction in Southern California by May, 2005.

Ingen President and CEO Scott Sand said, “We are pleased to sign Agroworx to begin the Pure Produce� program in California and Asia. Pre-tax profits from Pure Produce� and its first facility are expected to add another $1.2M to Ingen Technologies before the end of 2005. Our directors, Khoo Yong Sin and Chris Wirth, have spear-headed this project and bring valuable knowledge and experience to this program.”

The Ingen Technologies, Inc. Pure Produce� Facility is designed to offer the utmost in vegetable growth efficiency, without pesticides.� The Agro-facility will offer the most efficient use of water and energy conservation, while offering the best insulator towards food security.� More than 20% Pre-Tax Profit can be expected.

The main competitive advantage of the facility is be able to deliver off-season, high profit margin gourmet vegetables, herbs and edible flowers.� The produce grown can be customized for local consumption or be grown for specific export markets. Clean fresh produce without use of dirt, disease, insects and pesticides represent a $15B/yr. market and growing. Natural Nutriceuticals need increased useable biomass with continuous “laboratory like” conditions and this represents a $13B/yr market and growing. Pharmaceuticals, (molecular farming) have increased useable pharmacology through genetic enhancement. This fledgling industry is about ready to produce a *New Big Bang* in the biotech industry. The idea is to use these molecular crops as biological factories to generate drugs difficult or expensive to produce in any other way. This market will exceed $100B/yr by 2015.

About Ingen Technologies

Ingen Technologies, Inc. is a public company trading on OTC: IGTN. In business since 1999, Ingen Technologies is a growth-oriented technology company that offers a diverse and progressive service and product line.

The Company’s flagship products are its BAFI�, GasAlert� and OxyAlert� products, the world’s first wireless digital low gas warning system for pressurized gas cylinders. The BAFI� received a US Patent on October 24th, 2000, Patent No. 6,137,417. BAFI�, now in its second generation, is an accurate and cost-effective, real-time pressurized gas warning system that will alert users when gas levels are approaching empty.

The BAFI� line has multiple applications, inclusive but not limited to, the Medical Industry, Home Consumer, Residential Development Industry, Safety & Protection (fire and police), Aircraft Industry, and the Recreational Vehicle Industry. BAFI� meets or exceeds regulatory compliance of this type of product and is completed and in production.

The successful Secure Balance� program is equipment, training and an educational support system available to physicians throughout the United States. During the initial twelve months, the Secure Balance� system generated approximately $1 million in revenues for Ingen and is now being aggressively marketed throughout the United States. More recently, the company’s sales have increased in proportion to the expansion of the Company’s marketing network. Its marketing strength is based upon superior products and an experienced, professional team.

The Secure Balance� program offers the most sophisticated clinical products for vestibular function testing and balance therapy compared to any of their competitors. With more than two million people visiting their doctor each year complaining of dizziness and vertigo; Secure Balance � can substantially help patients regain their balance and decrease the number of fall related injuries. The elderly population is expected to double over the next decade and comprise the majority of balance disorder patients.

�
For more information, visit: www.otcfn.com/igtn and www.ingen-tech.com


Investor Relations Contact: �Scott R. Sand, C.E.O & Chairman
�����Ingen Technologies, Inc.
�����285 E. County Line Road
�����Calimesa, CA 92320
�����800-259-9622
�����951-675-3266
�����800-777-1186 FAX
�����[email protected]

�����Rick McCaffrey, Investor Relations
�����OTC Financial Network
�����781-444-6100 x625
�����781-444-6101 FAX
�����[email protected]


Safe Harbor for Forward-Looking Statements:� This news release includes forward-looking statements that are made pursuant to “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.

Download this article in PDF format: News20050120.pdf